Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Can Prognostic Factors Guide the Treatment of DLBCL?
Read More
Newly Discovered Genes in AML Can Identify Likely Response to Therapies
Read More
Leukemia
,
Oncology
Molecular and Cytogenetic Assessments Infrequently Performed in Patients with CML Receiving First-Line Imatinib
Read More
NIH Research Funding Cuts Would Have Devastating Impact on Hematology
Read More
Leukemia
,
Oncology
Alternatives to “7 + 3” Induction Therapy for AML Are Emerging
Read More
Leukemia
,
Oncology
Fast Response Identifies Patients with CML for Entry into Studies of Imatinib Discontinuation
Read More
Leukemia
,
Oncology
“Dramatic” Responses with Targeted Agent for Patients with CLL
Read More
Leukemia
,
Oncology
New Oral TKI Ponatinib Produces High Response Rates in Hard-to-Treat Leukemia
Read More
Rivaroxaban More Cost-Effective than Warfarin for Recurrent VTE Prevention
Read More
Costs of Second-Line Metastatic Colorectal Cancer Treatments Compared
Read More
181
182
183
184
185
186
187
Page 184 of 245
Results 1831 - 1840 of 2441
